How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
PET Imaging Study of 68Ga-FAPI-46 Biodistribution in cancer patients (FAPI Basket 3)
Description:
To define the biodistribution of 68Ga-FAPi-46 in normal and cancer tissues of patients with various malignancies measured by standardized uptake values (SUV). The goal is to determine where and to which degree 68Ga-FAPi-46 accumulates in normal and cancer tissues.
Sponsor:
Jonsson Comprehensive Cancer Center (UCLA)
Contacts:
Andrew Nguyen (Staff Research Associate)andtnguyen@mednet.ucla.edu
(310)-206-2466
Yuzin Arias Gonzalez (Clinical Research Coordinator)yariasgonzalez@mednet.ucla.edu
(310) 206-7372
Lela Theus (Clinical Research Coordinator)ltheus@mednet.ucla.edu
(310)-794-1589
Government Study Link:
NCT07118176 - Click here to see study onClinicalTrials.gov
Isotope(s):
Target(s):
- FAP
Ligand: Small Molecules
Inclusion
- • Patient is ≥ 18 years old at the time of the radiotracer administration.
- • Patient can remain still for duration of imaging procedure (up to one hour)
- • Patient can provide written informed consent.
Exclusion
- • Patient is pregnant or nursing.
Patient Education
Patient Education Not Yet Provided
Publications
Publications Not Yet Provided
Locations
United States 🇺🇸
University of California Los Angeles, Nuclear Medicine Clinic
Los Angeles, California, United States
